Skip to main content
Figure 4 | Virology Journal

Figure 4

From: Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients

Figure 4

Clinical courses of initial HBeAg-negative patients after lamivudine cessation. Virologic relapse (A), biochemical breakthrough (B), and hepatitis flare (C). Patients were grouped according to serum HBV DNA level at cessation of lamivudine treatment: Group A1, HBV DNA <50 copies/mL; Group B1, HBV DNA 50-104 copies/mL; Group C1, HBV DNA ≥104 copies/mL.

Back to article page

Virology Journal

ISSN: 1743-422X